- Home
- XENE vs CBZ Comparison
XENE vs CBZ Comparison
Compare XENE & CBZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XENE | CBZ |
|---|---|---|
| Founded | 1996 | 1987 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 2.7B |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | XENE | CBZ |
|---|---|---|
| Price | $43.74 | $53.23 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $53.91 | N/A |
| AVG Volume (30 Days) | ★ 793.2K | 683.3K |
| Earning Date | 11-03-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.66 |
| Revenue | $7,500,000.00 | ★ $2,675,607,000.00 |
| Revenue This Year | N/A | $55.67 |
| Revenue Next Year | N/A | $6.13 |
| P/E Ratio | ★ N/A | $32.24 |
| Revenue Growth | N/A | ★ 59.19 |
| 52 Week Low | $26.74 | $47.89 |
| 52 Week High | $46.60 | $90.13 |
Technical Indicators
Market Signals| Indicator | XENE | CBZ |
|---|---|---|
| Relative Strength Index (RSI) | 56.74 | 55.76 |
| Support Level | $42.89 | $49.89 |
| Resistance Level | $44.57 | $54.50 |
| Average True Range (ATR) | 1.42 | 1.86 |
| MACD | -0.07 | 0.48 |
| Stochastic Oscillator | 32.63 | 80.80 |
Price Performance
Historical ComparisonAbout XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
About CBZ CBIZ Inc.
CBIZ Inc through its subsidiaries provides professional services advisors to middle-market businesses and organizations nationwide. Its business units have been aggregated into three practice groups: Financial Services, Benefits and Insurance Services, and National Practices. The company provides its services to various industries such as Banking & Financial Services, Commercial Real Estate, Construction, Health Care Manufacturing & Distribution NFP & Education, Private Client Services, Professional Services, Public Sector, and Technology & Life Sciences. It derives the majority of its revenues from the Financial Services segment and geographically from the United States.